Ying‐Yang Liao

430 total citations
15 papers, 308 citations indexed

About

Ying‐Yang Liao is a scholar working on Hepatology, Cancer Research and Oncology. According to data from OpenAlex, Ying‐Yang Liao has authored 15 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ying‐Yang Liao's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Ying‐Yang Liao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Ying‐Yang Liao collaborates with scholars based in China and Italy. Ying‐Yang Liao's co-authors include Ning‐Fu Peng, Yufeng Yang, Hao Huang, Mei Yang, Le‐Qun Li, Jian‐Hong Zhong, Shu‐Guang Su, Le‐Qun Li, Bang‐De Xiang and Liang Ma and has published in prestigious journals such as PLoS ONE, Gynecologic Oncology and Journal of Surgical Oncology.

In The Last Decade

Ying‐Yang Liao

15 papers receiving 306 citations

Peers

Ying‐Yang Liao

ONCOL

PRM

EPIDE

Ning‐Fu Peng China

Olusola Olusesan Faluyi United Kingdom

Balázs Járay Hungary

Hayriye Tatlı Doğan Türkiye

A. Hackshaw United Kingdom

Benjamin Bonhomme France

Shulamit Rizel Israel

L. V. Manzyuk Russia

Peter Widschwendter Germany

Šárka Svobodová Czechia

Ning‐Fu Peng China

Ying‐Yang Liao

131 ×0.9

150 ×1.5

ONCOL

61 ×0.8

71 ×1.3

PRM

71 ×1.3

EPIDE

Citations per year, relative to Ying‐Yang Liao Ying‐Yang Liao (= 1×) peers Ning‐Fu Peng

Countries citing papers authored by Ying‐Yang Liao

Since Specialization

Citations

This map shows the geographic impact of Ying‐Yang Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Yang Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Yang Liao more than expected).

Fields of papers citing papers by Ying‐Yang Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Yang Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Yang Liao. The network helps show where Ying‐Yang Liao may publish in the future.

Co-authorship network of co-authors of Ying‐Yang Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Yang Liao. A scholar is included among the top collaborators of Ying‐Yang Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Yang Liao. Ying‐Yang Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Liao, Ying‐Yang, et al.. (2022). Artificial Intelligence Algorithm in Classification and Recognition of Primary Hepatic Carcinoma Images under Magnetic Resonance Imaging. Contrast Media & Molecular Imaging. 2022(1). 8950600–8950600. 2 indexed citations

Chen, Fu, Ying‐Yang Liao, Minjie Chen, et al.. (2021). Evaluation of the Efficacy of Sex Hormone–Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS. Reproductive Sciences. 28(9). 2504–2513. 18 indexed citations

Xu, Xiaojie, et al.. (2021). Involvement of TRPC7-AS1 Expression in Hepatitis B Virus-Related Hepatocellular Carcinoma. Journal of Oncology. 2021. 1–5. 11 indexed citations

Huang, Hao, et al.. (2020). Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis. Cancer Cell International. 20(1). 165–165. 64 indexed citations

Liao, Ying‐Yang, Rongrong Jia, Jing Cui, et al.. (2019). Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection. Journal of Cancer. 10(13). 3006–3011. 13 indexed citations

Liao, Ying‐Yang, et al.. (2019). Intra-Articular Viscosupplementation for Patients with Hip Osteoarthritis: A Meta-Analysis and Systematic Review. Medical Science Monitor. 25. 6436–6445. 10 indexed citations

Jia, Rongrong, Jian‐Hong Zhong, Rong‐Rui Huo, et al.. (2019). Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy. Journal of Surgical Oncology. 119(6). 794–800. 22 indexed citations

Liao, Ying‐Yang, et al.. (2018). Does delayed treatment affect the survival of patients with hepatocellular carcinoma. Translational Cancer Research. 7(3). 1 indexed citations

Liao, Ying‐Yang, et al.. (2018). Does delayed treatment affect the survival of patients with hepatocellular carcinoma?. Translational Cancer Research. 7(3). E14–E16. 4 indexed citations

10.

Liao, Ying‐Yang, Xue‐Mei You, Alessandro Cucchetti, et al.. (2017). Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PLoS ONE. 12(3). e0174222–e0174222. 10 indexed citations

11.

Liao, Ying‐Yang, Ning‐Fu Peng, Di Long, et al.. (2017). Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surgery. 17(1). 14–14. 22 indexed citations

12.

Yang, Yufeng, et al.. (2015). Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment. Gynecologic Oncology. 139(3). 419–423. 31 indexed citations

13.

Yang, Yufeng, et al.. (2014). Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients. Medical Oncology. 31(10). 214–214. 50 indexed citations

14.

Liao, Ying‐Yang, et al.. (2013). Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancer. Pathology - Research and Practice. 209(12). 797–802. 36 indexed citations

15.

Yang, Yufeng, et al.. (2012). Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Pathology - Research and Practice. 208(12). 708–712. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact